Tag: Eli Lilly and Co

‘Mag 7’ earnings, Fed meeting will test a stock market near all-time highs. Here’s what’s ahead

Amazon launches GLP-1 weight loss program, promising ‘fast, convenient’ access

UnitedHealth tops quarterly estimates, hikes profit outlook as insurer manages high medical costs

Eli Lilly agrees to acquire cancer drug maker Kelonia in deal worth up to $7 billion

Here’s our monthly update on all 31 portfolio stocks, including 3 on the buy list

Trump policies, China’s biotech boom are ending Europe’s pharma powerhouse era

As millions lose weight on GLP-1s, they’re starting to turn to retailers to refresh their wardrobes

Novo Nordisk’s explosive Wegovy pill launch draws a new wave of patients into GLP-1 weight loss treatment

Trump tariff fallout: Some industries grapple with lingering effects one year later

Trump administration prepares up to 100% pharmaceutical tariffs on some imported drugs